Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-06

Clinical Trial Update: A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating pembrolizumab with metformin versus pembrolizumab alone in adults with advanced melanoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pembrolizumab (pembrolizumab)
  • metformin (metformin)

Snippet

Sponsor: Yana Najjar | Conditions: Advanced Melanoma | Phase 1 | Status: RECRUITING